Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis can't convince judge to free it from kickbacks case
Fierce Pharma
Friday, August 8, 2014 - 11:45am
tags:
Novartis, kickbacks
Still Down? Tech Glitch Hobbles Pharma Payment Disclosure System
WSJ Online
Friday, August 8, 2014 - 11:42am
tags:
Physician Payment Sunshine Act, physicians
Salix Sinks In #PreMarket On Disappointing Outlook, Q2 Results
Yahoo/Benzinga
Friday, August 8, 2014 - 11:41am
tags:
Salix, earnings
VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales
Yahoo/Zacks.com
Friday, August 8, 2014 - 11:40am
tags:
Vivus, earnings
Biosimilar preclinical demand growing as US market beckons, says Harlan
Biopharma-Reporter
Friday, August 8, 2014 - 9:34am
tags:
biosimilars, Sandoz, Novartis, FDA
Fujifilm Drug Eyed As Possible Treatment for Ebola Virus
WSJ Online
Friday, August 8, 2014 - 9:12am
tags:
ebola virus, Fujifilm, favipiravir, Toyama Chemical Co.
Roche Rebuked by U.K. on $152,850 Breast Cancer Drug
Bloomberg
Friday, August 8, 2014 - 8:44am
tags:
UK, Roche, breast cancer, Kadcyla
Nicox to co-promote eye drug with Bausch + Lomb in the US
Yahoo/Reuters
Friday, August 8, 2014 - 8:43am
tags:
NicOx, Bausch & Lomb, Valeant Pharmaceuticals, latanoprostene
Ebola Drug Firm Shares Go Bonkers After FDA Announcement
Yahoo/Business Insider
Friday, August 8, 2014 - 8:42am
tags:
FDA, Tekmira Pharmaceuticals, TKM-EBOLA
[video] Glaxo trial begins in China
CNBC
Friday, August 8, 2014 - 8:39am
tags:
China, GSK
Even At $900 (Vs. $84,000 In US) Hep C Cure Sovaldi's Cost Could Be Unacceptable In India
Forbes
Friday, August 8, 2014 - 8:36am
tags:
India, Sovaldi, drug pricing, hepatitis C
Biotech firm Galapagos says GSK stops joint drug project
Yahoo/Reuters
Friday, August 8, 2014 - 8:36am
tags:
GSK, Galapagos, GSK2586184, ulcerative colitis
Pfizer confronts surge of lawsuits over Lipitor
Yahoo/Reuters
Friday, August 8, 2014 - 8:34am
tags:
Pfizer, Lipitor, diabetes
Most popular news headlines for Thursday, August 7 2014
CP Wire
Friday, August 8, 2014 - 8:14am
tags:
Allergan, M&A, Valeant Pharmaceuticals, tax inversions, PTC Therapeutics, Duchenne Muscular Dystrophy, ebola virus, Tekmira Pharmaceuticals
Vascular Biogenics ($VBLX) trading halted, will IPO be reversed?
CP Wire
Thursday, August 7, 2014 - 6:19pm
tags:
IPOs, Vascular Biogenics
UPDATED: Ebola drug developer Tekmira trading halted after volatile trading day, then gets potential big news from FDA
CP Wire
Thursday, August 7, 2014 - 5:07pm
tags:
Tekmira Pharmaceuticals, FDA, ebola virus
Takeda to Extend Global Reach
Drug Discovery and Development
Thursday, August 7, 2014 - 4:38pm
tags:
Takeda
Pharma shares sink as U.S. threatens tax-inversion crackdown
Fierce Pharma
Thursday, August 7, 2014 - 2:36pm
tags:
tax inversions, M&A, US Treasury
Is Durata's Antibiotic Overpriced? A Twitter Conversation
Forbes
Thursday, August 7, 2014 - 2:33pm
tags:
Durata Therapeutics, antibiotics, twitter, social media, Dalvance, The Medicines Company, oritavancin
NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales
Yahoo/Zacks.com
Thursday, August 7, 2014 - 2:24pm
tags:
earnings, NPS Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.